- Lobbying
- Gary AND Heimberg
Lobbying Arrangements Results for 'Gary Heimberg'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Regulation of marketed unapproved drugs |
Medimetriks Pharmaceuticals Inc
|
COVINGTON & BURLING LLP | |||
Details Policy regarding demonstration of effectiveness for new drug approvals. |
Fabre-Kramer Pharmaceuticals, Inc
|
COVINGTON & BURLING LLP | |||
Details Discussions on client's background, sites, products, and pipeline generally. |
BeiGene USA, Inc.
|
COVINGTON & BURLING LLP | |||
Details Policy development regarding HIV and Avian Influenza |
Constella Group, LLC
Life sciences company providing health intelligence and innovative technology services in markets... |
AKIN GUMP STRAUSS HAUER & FELD | |||
Details FDA appropriations |
The Coalition For A Stronger FDA
Coalition of aprx 50 consumer/health related organizations advocating for increased appropriation... |
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Expansion of priority review voucher programs to include snake bite envenoming. |
Ophirex, Inc.
|
COVINGTON & BURLING LLP | |||
Details Education and support for public policies that promote the development, use, coverage and reimbursement of novel, non-opioid pain therapies. |
Flexion Therapeutics, Inc.
|
COVINGTON & BURLING LLP | |||
Details Policy issues related to molecular diagnostics and personalized medicine |
Third Wave Technologies, Inc.
Developer and marketer of molecular diagnostics for a variety of DNA and RNA analysis applications |
AKIN GUMP STRAUSS HAUER & FELD LLP | |||
Details Stockpiling of diagnostic ingredients |
EMD Millipore
|
COVINGTON & BURLING LLP | |||
Details Standards for developing synthetic alternatives for bacterial endotoxin testing |
Charles River Laboratories
|
COVINGTON & BURLING LLP | |||
Details Enhanced investment in biomanufacturing; investment in workforce development, infrastructure, and R&D for synthetic biology; shoring up manufacturing supply chains for critical pharmaceutical ingre... |
ZYMERGEN INC.
|
COVINGTON & BURLING LLP | |||
Details Higher education issues |
Inter-American University of Puerto Rico
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Legislation and rulemakings relating to opioid abuse and Naloxone access; H.R. 4007, the HEAL Act; H.R. 4531, the Support for Patients and Communities Reauthorization Act. |
Adamis Pharmaceuticals Corporation
|
COVINGTON & BURLING LLP | |||
Details OTC drugs, cosmetics and self-care in general, including issues around drug shortages, PAHPA re-authorization, implementation of MOCRA and dietary supplement reform. (Lobbying activity conducted o... |
Johnson & Johnson Services, Inc.
|
COVINGTON & BURLING LLP | |||
Details Telehealth triage service related to COVID-19 |
Roman Health Ventures Inc.
|
COVINGTON & BURLING LLP | |||
Details Education and support for policies and funding to advance turnkey, co-located, on-demand pharma grade research laboratory environments, including the House and Senate Pandemic and All-Hazards Prepa... |
SL 2T, LLC ("SmartLabs")
|
COVINGTON & BURLING LLP | |||
Details Delivery system reform, implementation. |
MDVIP, Inc.
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Education and support for public policies related to the research and development of, and access to, FDA-approved therapies containing CBD or other cannabinoids; H.R. 841, Hemp and Hemp-Derived CBD... |
Greenwich Biosciences, Inc.
|
COVINGTON & BURLING LLP | |||
Details Expressing support for changes to the CREATES Act (S. 340) and Fair Access for Safe and timely (FAST) Generics Act (H.R. 985) |
Celgene Corporation
|
COVINGTON & BURLING LLP | |||
Details Federal cosmetic legislation. |
CHANEL, INC.
|
COVINGTON & BURLING LLP | |||
Details Issues related to COVID-19 crisis, provider relief funding, ensuring patient access to telehealth services, promoting patient-centered care. |
Alliance of Dedicated Cancer Centers
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Re-shoring production of essential medicine |
1776 Pharmaceuticals LLC
|
COVINGTON & BURLING LLP | |||
Details Issues related to precision medicine, laboratory developed tests and next generation sequencing. |
Illumina, Inc.
|
COVINGTON & BURLING LLP | |||
Details Coverage and payment for multi-function ventilators |
Ventec Life Systems, Inc.
|
COVINGTON & BURLING LLP | |||
Details Regulatory issues relating to the Food & Drug Administration and Medicare; federal procurement advocacy; consumer privacy issues; health information privacy issues |
Catalina Marketing
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Coverage of CDC recommended vaccines. |
Valneva USA, Inc.
|
COVINGTON & BURLING LLP | |||
Details Drug pricing policies, including The Safe Step Act. |
Horizon Therapeutics USA, Inc. (formerly Horizon Pharma USA, Inc.)
|
COVINGTON & BURLING LLP | |||
Details Food labeling; nutrition issues. H.R. 6, 21st Century Cures Act. |
Abbott Laboratories
Pharmaceuticals. |
COVINGTON & BURLING LLP | |||
Details IT Modernization; Data Sharing. Cybersecurity and Surveillance Privacy Issues. Tax Reform Legislation; Digital tax issues. |
SAP America, Inc.
|
COVINGTON & BURLING LLP | |||
Details Induced infringement and generic drug labeling; Biopharmaceutical innovation and intellectual property policy issues. Give Kids a Chance Act of 2023 (H.R. 3433); Affordable Prescriptions for Patien... |
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA, INC.
|
COVINGTON & BURLING LLP | |||
Details Medicare reimbursement issues. |
Sunovion Pharmaceuticals, Inc. (formerly known as Sepracor Inc.)
|
COVINGTON & BURLING LLP | |||
Details Policy and budgetary matters related to aerospace industries. Federal government appropriations and procurement of aircraft platforms. H.R. 2670 and S. 2226, National Defense Authorization Act for... |
Bombardier Aerospace (Holdings) USA Inc. (former client Bombardier Transit Corp)
|
COVINGTON & BURLING LLP | |||
Details Prescription Drug Costs. H.R.5429/S.2780: Medication Affordability and Patent Integrity Act. 180-Day Exclusivity. S.1114: Expanding Access to Low-Cost Generics Act of 2023. H.R.5461/S.2129: Ensurin... |
Association for Accessible Medicines
|
in-house lobbying | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
GSK (fka GLAXOSMITHKLINE INC.)
|
in-house lobbying | |||
Details |
UNITED SURGICAL PARTNERS INTERNATIONAL, INC
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details |
COMMUNITY ONCOLOGY ALLIANCE
|
AKIN GUMP STRAUSS HAUER & FELD |